Preoperative Inflammatory Control and Surgical Outcome of Vitrectomy in Intermediate Uveitis
Table 3
Comparison of the postoperative inflammation control and BCVA between the two groups classified based on complete control of intraocular inflammation before vitrectomy.
Complete control of inflammation before vitrectomy
Yes
No
value
Number (patients)
36
30
Postoperative follow-up period (months)
44.92 ± 36.41
54.37 ± 44.23
0.345
BCVA at final follow-up
0.45 ± 0.57
0.37 ± 0.41
0.516
Postoperative uveitic attack
11 (30.6%)
11 (36.7%)
0.600†
The average number of uveitic attacks in the postoperative period (per year)
0.19 ± 0.44
0.29 ± 0.52
0.400
The average number of local injections in the postoperative period (per year)
0.06 ± 0.34
0.13 ± 0.41
0.476
The grade of vitreous haze at final follow-up
0.03 ± 0.17
0.10 ± 0.31
0.252
The average number of systemic medications at final follow-up
0.31 ± 0.57
0.47 ± 0.77
0.351
The duration when postoperative inflammation disappeared (months)
1.74 ± 1.02
2.58 ± 1.47
0.012
BCVA: best-corrected visual acuity (in logarithm of the minimal angle of resolution); value was calculated using an independent t-test or Pearson’s chi-square test†.
